NL-OMON28758暂停不适用
Budesonide as treatment for patients with irritable bowel syndrome.
未提供0 个研究点目标入组 32 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 32
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Fulfilling Rome II criteria of IBS, 18-65 years of age, no other organic abnormalities explaining the complaints.
排除标准
- •Severe comorbidity, pregnancy/lactation.
研究者
相似试验
已完成
不适用
Irritable Bowel Syndrome: BudesonideIrritable bowel syndrome (IBS)Digestive SystemIrritable bowel syndromeISRCTN31751611Academic Medical Centre (AMC) (The Netherlands)32
已完成
3 期
Budesonide for Induction of Remission in Incomplete Microscopic ColitisIncomplete Microscopic ColitisNCT02142634Dr. Falk Pharma GmbH44
招募中
2 期
Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosisCrohn's diseaseJPRN-jRCT1051190043Takehara Tetsuo15
已完成
不适用
Safety and efficacy of Budesonide administration after endoscopic ballon dilation for Crohn disease patients with intestinal stenosiss diseaseCrohn's diseaseJPRN-UMIN000031839Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology17
已完成
3 期
Budesonide Treatment for Lymphocytic ColitisMicroscopic ColitisNCT00180050Technische Universität Dresden40